{{Rsnum
|rsid=9883654
|Chromosome=3
|position=153004186
|Orientation=plus
|GMAF=0.4853
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 50.4 | 18.6
| HCB | 29.4 | 52.2 | 18.4
| JPT | 27.4 | 51.3 | 21.2
| YRI | 15.1 | 46.6 | 38.4
| ASW | 24.6 | 43.9 | 31.6
| CHB | 29.4 | 52.2 | 18.4
| CHD | 26.6 | 56.0 | 17.4
| GIH | 37.6 | 47.5 | 14.9
| LWK | 11.0 | 43.1 | 45.9
| MEX | 25.9 | 41.4 | 32.8
| MKK | 14.1 | 46.8 | 39.1
| TSI | 31.4 | 47.1 | 21.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21659360
|Trait=None
|Title=Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial.
|RiskAllele=T
|Pval=0.000002
|OR=2.2000
|ORtxt=[1.57-3.08]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}